Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BMP Pharma Trading AGSTU:BMP +1.61%36 3-Year EBITDA Growth Rate is 19.50% as of Dec. 2025, which is 30% below its 10-year median of 27.70. GuruFocus rates STU:BMP with a GF Score™ of 36/100. The stock has 2 warning signs investors should review. Among 105 Medical Distribution companies, BMP Pharma Trading AG ranks better than 76.19% on this metric.
During the past 12 months, BMP Pharma Trading AG's average EBITDA Per Share Growth Rate was -9.30% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was 19.50% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was 49.70% per year.
During the past 10 years, the average EBITDA Per Share Growth Rate was 42.10% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of BMP Pharma Trading AG was 139.30% per year. The lowest was -39.20% per year. And the median was 27.70% per year.
BMP Pharma Trading AG (STU:BMP) 3-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
BMP Pharma Trading AG 3-Year EBITDA Growth Rate Related Terms
STU:BMP vs MCK, COR, CAH: 3-Year EBITDA Growth Rate Comparison
For the Medical Distribution subindustry, BMP Pharma Trading AG's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BMP Pharma Trading AG 3-Year EBITDA Growth Rate vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, BMP Pharma Trading AG's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where BMP Pharma Trading AG's 3-Year EBITDA Growth Rate falls into.
BMP Pharma Trading AG 3-Year EBITDA Growth Rate Calculation
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 19.50% mean?
BMP Pharma Trading AG (STU:BMP) has a 3-Year EBITDA Growth Rate of 19.50% as of Dec. 2025. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for BMP Pharma Trading AG and its competitors. This is 30% below median its historical median of 27.70. According to the industry distribution chart, BMP Pharma Trading AG ranks #25 out of 105 companies in the Medical Distribution industry, placing it in the top 23.8%.
Is BMP Pharma Trading AG's 3-Year EBITDA Growth Rate too high?
BMP Pharma Trading AG's current 3-Year EBITDA Growth Rate of 19.50% is 30% below median its 10-year median of 27.70. The Medical Distribution industry median 3-Year EBITDA Growth Rate is 5.40. BMP Pharma Trading AG's value of 19.50% is 261.1% above this industry median. Based on the distribution chart, BMP Pharma Trading AG ranks #25 out of 105 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, BMP Pharma Trading AG has a GF Score™ of 36/100, reflecting its overall financial health beyond just this single metric.
How does BMP Pharma Trading AG's 3-Year EBITDA Growth Rate compare to MCK and COR?
According to the Medical Distribution industry distribution chart, BMP Pharma Trading AG ranks #25 out of 105 companies for 3-Year EBITDA Growth Rate. This places BMP Pharma Trading AG in the top 24% of its industry — outperforming the majority of peers. The industry median 3-Year EBITDA Growth Rate is 5.40. BMP Pharma Trading AG's value of 19.50% is 261.1% above this benchmark. While the company's 10-year median is 27.70 vs. the industry median of 5.40, BMP Pharma Trading AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Medical Distribution company?
The median 3-Year EBITDA Growth Rate among Medical Distribution companies is 5.40, based on 105 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. BMP Pharma Trading AG's current 3-Year EBITDA Growth Rate of 19.50% is 261.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for BMP Pharma Trading AG and its competitors. For the Medical Distribution industry, the median 3-Year EBITDA Growth Rate is 5.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BMP Pharma Trading AG's current 3-Year EBITDA Growth Rate is 19.50%, which is 30% below median its own 10-year median of 27.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BMP Pharma Trading AG stock overvalued right now?
BMP Pharma Trading AG (STU:BMP) has a current 3-Year EBITDA Growth Rate of 19.50%. The current 3-Year EBITDA Growth Rate is 19.50%, which is 30% below median its 10-year median of 27.70 and 261.1% above the Medical Distribution industry median of 5.40. BMP Pharma Trading AG's overall GF Score™ is 36/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For BMP Pharma Trading AG (STU:BMP), the current 3-Year EBITDA Growth Rate is 19.50% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
BMP Pharma Trading AG is a German company engaged in trading of pharmaceutical raw materials, food supplement products, and veterinary raw materials. The services offered by the company include development of microbial processes, Transfer of biotechnological processes, Contract production of biotechnologically and biocatalysts and development of chiral syntheses.
36GF Score
Get the complete analysis for STU:BMP
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:BMP has been successfully added to your 
